Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer

NCT04781413 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Stage IIIC Gastric Cancer

Interventions

DRUG: Nab-PTX, Sintilimab, S-1

Sponsor

Ruijin Hospital